In order to explore in more depth the inflammatory process that occurs in type 2 diabetes, we measured the levels of inflammation markers TNF-α, ICAM-1 and MPO in serum, and compared the leukocyte–endothelium interactions in type 2 diabetic participants with those in healthy participants. The gene discussed is MPO; the disease is type 2 diabetes mellitus.